Mobilization With Movement in Patients With Osteoarthritis of the Hip

NCT02390336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-05-28

No results posted yet for this study

Summary

The concept of mobilization with movement, also referred to as a Mulligan mobilization, has not been studied in patients with hip osteoarthritis, subsisting questions about the possible effects in this population. The aim of this randomized controlled study is to compare the immediate effects of Mulligan mobilization with movement technique of pain, range of motion and physical function in patients with osteoarthritis of the hip.

Conditions

  • Osteoarthritis Hip
  • Joint Disease
  • Musculoskeletal Diseases
  • Pathologic Processes

Interventions

OTHER

Real mobilization-with-movement (MWM)

For the MWM group, the investigator applied two techniques of mobilization with movement: one for flexion and one for medial rotation of the hip. With the hip in flexion, a stabilizing belt was placed on the medial side of the participant's thigh closest to the joint interline. The belt was placed around the pelvic region of the physical therapist, keeping a perpendicular direction to the participant's thigh. Maintaining a side slip, it was carried out a passive movement of 1) hip flexion (3x10) and 2) medial hip rotation (3x10) by the physiotherapist throughout painless amplitude.

OTHER

Sham mobilization-with-movement (MWM)

In the sham group, the investigators conducted a technical simulation. The positioning of the patient and the physical therapist was the same, however, no accessory mobilization was performed with the help of the belt and did not performed repeated movements of passive flexion or medial rotation.

Sponsors & Collaborators

  • Natália Maria Oliveira Campelo

    lead OTHER

Principal Investigators

  • Natália Campelo, PhD · Polytechnic Institute of Porto (Portugal)

  • Francisco Neto, MSc · Polytechnic Institute of Porto (Portugal)

  • Carlos Beselga, MSc · Polytechnic Institute of Porto (Portugal)

  • Francisco A Sendín, PhD · University of Salamanca (Spain)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-05-31
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02390336 on ClinicalTrials.gov